4/9
07:00 am
rani
Rani Therapeutics Appoints Dr. Sara Kenkare-Mitra as Strategic Advisor to Advance Platform and Clinical Strategy
Medium
Report
Rani Therapeutics Appoints Dr. Sara Kenkare-Mitra as Strategic Advisor to Advance Platform and Clinical Strategy
4/1
05:17 pm
rani
Rani Therapeutics (RANI) had its price target lowered by Canaccord Genuity Group Inc. from $9.00 to $5.00. They now have a "buy" rating on the stock.
Medium
Report
Rani Therapeutics (RANI) had its price target lowered by Canaccord Genuity Group Inc. from $9.00 to $5.00. They now have a "buy" rating on the stock.
3/28
08:10 am
rani
Companies Like Rani Therapeutics Holdings (NASDAQ:RANI) Are In A Position To Invest In Growth [Yahoo! Finance]
High
Report
Companies Like Rani Therapeutics Holdings (NASDAQ:RANI) Are In A Position To Invest In Growth [Yahoo! Finance]
3/27
08:02 am
rani
Rani Therapeutics (RANI) had its "buy" rating reaffirmed by HC Wainwright. They now have a $11.00 price target on the stock.
High
Report
Rani Therapeutics (RANI) had its "buy" rating reaffirmed by HC Wainwright. They now have a $11.00 price target on the stock.
3/26
08:17 pm
rani
Rani Therapeutics Holdings, Inc. (RANI) Q4 2025 Earnings Call Transcript [Seeking Alpha]
High
Report
Rani Therapeutics Holdings, Inc. (RANI) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/26
05:56 pm
rani
Rani Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]
High
Report
Rani Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]
3/26
04:39 pm
rani
Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate Update [Yahoo! Finance]
High
Report
Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate Update [Yahoo! Finance]
3/26
04:05 pm
rani
Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate Update
High
Report
Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate Update
3/25
04:53 pm
rani
Rani Therapeutics Appoints Jesper Høiland as Head of Strategy to Advance Corporate and Pipeline Prioritization
Medium
Report
Rani Therapeutics Appoints Jesper Høiland as Head of Strategy to Advance Corporate and Pipeline Prioritization
3/19
04:55 pm
rani
Rani Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Low
Report
Rani Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
3/19
04:05 pm
rani
Rani Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results
Low
Report
Rani Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results
3/17
12:20 pm
rani
Surf Therapeutics Reports Positive First-in-Human Data and Secures Additional Financing, Bringing Total Funding to $6M as Rheumatoid Arthritis Clinical Study Begins [Yahoo! Finance]
Low
Report
Surf Therapeutics Reports Positive First-in-Human Data and Secures Additional Financing, Bringing Total Funding to $6M as Rheumatoid Arthritis Clinical Study Begins [Yahoo! Finance]
1/28
10:48 am
rani
Rani Therapeutics Announces the Promotion of Alireza Javadi, Ph.D. to Chief Technical Officer [Yahoo! Finance]
Medium
Report
Rani Therapeutics Announces the Promotion of Alireza Javadi, Ph.D. to Chief Technical Officer [Yahoo! Finance]
1/28
07:00 am
rani
Rani Therapeutics Announces the Promotion of Alireza Javadi, Ph.D. to Chief Technical Officer
Medium
Report
Rani Therapeutics Announces the Promotion of Alireza Javadi, Ph.D. to Chief Technical Officer